• Definium Therapeutics issued inducement stock options covering 169,740 common shares to eight newly hired non-executive employees.
• Options carry an exercise price set at the closing share price on the July 6, 2026 grant date.
• Vesting runs four years: 25% after one year, remaining 75% in substantially equal monthly installments over the next three years.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Definium Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202607061601BIZWIRE_USPR_____20260706_BW280056) on July 06, 2026, and is solely responsible for the information contained therein.